ASMBS Position Statement on Postprandial Hyperinsulinemic H ypoglycemia after Bariatric Surgery

被引：88
|
作者：
Eisenberg, Dan [1 ,2 ]
Azagury, Dan E. [3 ]
Ghiassi, Saber [4 ,5 ]
Grover, Brandon T. [6 ]
Kim, Julie J. [7 ]
机构：
[1] Stanford Sch Med, Dept Surg, Stanford, CA USA
[2] Palo Alto VA Hlth Care Syst, Dept Surg, Palo Alto, CA USA
[3] Stanford Univ, Sch Med, Sect Bariatr & Minimally Invas Surg, Stanford, CA 94305 USA
[4] Yale Sch Med, New Haven, CT USA
[5] Bridgeport Hosp, Dept Surg, Fairfield, CT USA
[6] Gundersen Hlth Syst, Dept Surg, La Crosse, WI USA
[7] Tufts Univ, Sch Med, Dept Gen Surg, Boston, MA USA
来源：
SURGERY FOR OBESITY AND RELATED DISEASES | 2017年 / 13卷 / 03期
关键词：
Y-GASTRIC-BYPASS; ALPHA-GLUCOSIDASE INHIBITOR; PARTIAL PANCREATECTOMY; LAPAROSCOPIC REVERSAL; INSULIN-SECRETION; WEIGHT-LOSS; HYPOGLYCEMIA; NESIDIOBLASTOSIS; MANAGEMENT; NEUROGLYCOPENIA;
D O I：
10.1016/j.soard.2016.12.005
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：371 / 378
页数：8
相关论文
共 50 条
  • [41] Effects of Lisosan-G on postprandial hypoglycaemia after bariatric surgery
    Moriconi, D.
    Baldi, S.
    Antonioli, L.
    Pucci, L.
    Taddei, S.
    Nannipieri, M.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S240 - S240
  • [42] Reply to “New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy”
    Dan Eisenberg
    Scott A. Shikora
    Shanu N. Kothari
    Obesity Surgery, 2023, 33 : 2594 - 2595
  • [43] DEMONSTRABLE COMORBIDITY RESOLUTION ONE YEAR AFTER BARIATRIC SURGERY USING THE NEW ASMBS OUTCOME REPORTING STANDARDS
    Monpellier, V.
    Kooiman, L.
    Swank, D.
    Janssen, I.
    OBESITY SURGERY, 2018, 28 : 295 - 295
  • [44] IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures
    Wendy A. Brown
    Yazmin Johari Halim Shah
    George Balalis
    Ahmad Bashir
    Almino Ramos
    Lilian Kow
    Miguel Herrera
    Scott Shikora
    Guilherme M. Campos
    Jacques Himpens
    Kelvin Higa
    Obesity Surgery, 2020, 30 : 3135 - 3153
  • [45] IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures
    Brown, Wendy A.
    Shah, Yazmin Johari Halim
    Balalis, George
    Bashir, Ahmad
    Ramos, Almino
    Kow, Lilian
    Herrera, Miguel
    Shikora, Scott
    Campos, Guilherme M.
    Himpens, Jacques
    Higa, Kelvin
    OBESITY SURGERY, 2020, 30 (08) : 3135 - 3153
  • [46] The Asian perspective to the International Diabetes Federation's position statement on bariatric surgery for diabetes
    Lakdawala, M.
    Bhasker, A. G.
    ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2012, 5 (03) : 103 - 104
  • [47] Reply to "New IFSO/ASMBS Indications for Metabolic and Bariatric Surgery? Yes, After Failure of Best Nonsurgical Therapy"
    Eisenberg, Dan
    Shikora, Scott A.
    Kothari, Shanu N.
    OBESITY SURGERY, 2023, 33 (08) : 2594 - 2595
  • [48] American Society for Metabolic and Bariatric Surgery position statement on vagal blocking therapy for obesity
    Papasavas, Pavlos
    El Chaar, Maher
    Kothari, Shanu N.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2016, 12 (03) : 460 - 461
  • [49] Barrett's Oesophagus and Bariatric/Metabolic Surgery-IFSO 2020 Position Statement
    Fisher, Oliver M.
    Chan, Daniel L.
    Talbot, Michael L.
    Ramos, Almino
    Bashir, Ahmad
    Herrera, Miguel F.
    Himpens, Jacques
    Shikora, Scott
    Higa, Kelvin D.
    Kow, Lilian
    Brown, Wendy A.
    OBESITY SURGERY, 2021, 31 (03) : 915 - 934
  • [50] American Society for Metabolic and Bariatric Surgery position statement on accreditation of bariatric surgery centers endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons
    DeMaria, Eric J.
    El Chaar, Maher
    Rogers, Ann M.
    Eisenberg, Dan
    Kallies, Kara J.
    Kothari, Shanu N.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2016, 12 (05) : 946 - 954
12345